Orexigen Therapeutics to Present at the Jefferies 2012 Global Healthcare Conference

_{//health-fitness.news-articles.net/content/2012/ .. jefferies-2012-global-healthcare-conference.html}
^{Published in Health and Fitness on Thursday, May 31st 2012 at 4:46 GMT by Market Wire}  

Orexigen Therapeutics to Present at the Jefferies 2012 Global Healthcare Conference -- SAN DIEGO, May 31, 2012 /PRNewswire/ --

[ ]

My news for Investors

AtLeast one of the check box should be selected You are following news about Follow the latest news about OREX

SAN DIEGO, May 31, 2012 /PRNewswire/ -- Orexigen® Therapeutics, Inc. (Nasdaq: [ OREX ]) today announced that management will present a company overview at the Jefferies 2012 Global Healthcare Conference in New York. The presentation is scheduled for Wednesday, June 6th at 9:30 a.m. EDT at the Grand Hyatt New York. To listen to the live webcast or a replay of the presentation, please visit the Investor Relations section of the Company's website at [ www.orexigen.com ]. A replay will be available for 14 days after the event.

About Orexigen® Therapeutics

Orexigen Therapeutics, Inc. is a biopharmaceutical company focused on the treatment of obesity. The Company's lead product candidate is Contrave®, which has completed Phase III clinical trials and for which a New Drug Application has been submitted and reviewed by the FDA. The Company has also reached agreement with the FDA on a Special Protocol Assessment for the Contrave cardiovascular outcomes trial which the company plans to initiate this quarter. The Company's other product candidate, Empatic™, has completed Phase II clinical trials. Further information about the Company can be found at [ www.orexigen.com ].

SOURCE Orexigen Therapeutics, Inc.

RELATED LINKS
[ http://www.orexcigen.com ]